A recent report indicated that CA XII cooperates with P-GP secretion in drug-resistant cancer cells to exert drug resistance.137 The results displayed that the CA XII inhibitors, either small molecules or antibodies, significantly inhibited cell resistance when combined with chemotherapeutic agents targeting P-GP substrate therapy. The gene discussed is CA12; the disease is cancer.